
Stomach Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy & Surgery), Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), Drug Class, Route of Administration, Distributi
Description
Stomach Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy & Surgery), Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), Drug Class, Route of Administration, Distribution Channel - Global Forecast 2024-2030
The Stomach Cancer Treatment Market size was estimated at USD 5.09 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 9.53% to reach USD 9.63 billion by 2030.
Global Stomach Cancer Treatment Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Stomach Cancer Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Stomach Cancer Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Stomach Cancer Treatment Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Company, Celltrion Healthcare Co., Ltd., Eli Lilly and Company, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Imugene Limited, Jiangsu Hengrui Medicine Co., Ltd., Merck KGaA, Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., and Samsung Bioepis Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Stomach Cancer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
Treatment
Chemotherapy
Immunotherapy
Radiation Therapy & Surgery
Targeted Therapy
Disease Indication
Gastric Cancer/Gastroesophageal Junction Cancer
Gastrointestinal Stromal Tumors
Drug Class
HER2 Antagonists
PD-1/PD-L1 Inhibitors
VEGFR2 Antagonists
Route of Administration
Injectable
Oral
Distribution Channel
Hospital Pharmacies
Specialty & Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Stomach Cancer Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Stomach Cancer Treatment Market?
3. What are the technology trends and regulatory frameworks in the Stomach Cancer Treatment Market?
4. What is the market share of the leading vendors in the Stomach Cancer Treatment Market?
5. Which modes and strategic moves are suitable for entering the Stomach Cancer Treatment Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Stomach Cancer Treatment Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising geriatric population with a high risk for the development of stomach cancer
- 5.1.1.2. Increasing cases of diabetic and obese patients coupled with sedentary & unhealthy lifestyle
- 5.1.1.3. Growing emphasis on early screening and detection
- 5.1.2. Restraints
- 5.1.2.1. Dearth of gastroenterologists professionals and limited availability of scanning & treatment for timely diagnosis
- 5.1.3. Opportunities
- 5.1.3.1. Continuous technological advancements in treatments and diagnostic methods for stomach cancer
- 5.1.4. Challenges
- 5.1.4.1. Side effects related to treatments
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Stomach Cancer Treatment Market, by Treatment
- 6.1. Introduction
- 6.2. Chemotherapy
- 6.3. Immunotherapy
- 6.4. Radiation Therapy & Surgery
- 6.5. Targeted Therapy
- 7. Stomach Cancer Treatment Market, by Disease Indication
- 7.1. Introduction
- 7.2. Gastric Cancer/Gastroesophageal Junction Cancer
- 7.3. Gastrointestinal Stromal Tumors
- 8. Stomach Cancer Treatment Market, by Drug Class
- 8.1. Introduction
- 8.2. HER2 Antagonists
- 8.3. PD-1/PD-L1 Inhibitors
- 8.4. VEGFR2 Antagonists
- 9. Stomach Cancer Treatment Market, by Route of Administration
- 9.1. Introduction
- 9.2. Injectable
- 9.3. Oral
- 10. Stomach Cancer Treatment Market, by Distribution Channel
- 10.1. Introduction
- 10.2. Hospital Pharmacies
- 10.3. Specialty & Retail Pharmacies
- 11. Americas Stomach Cancer Treatment Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Stomach Cancer Treatment Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Stomach Cancer Treatment Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. AstraZeneca PLC
- 15.1.2. Bayer AG
- 15.1.3. Bristol Myers Squibb Company
- 15.1.4. Celltrion Healthcare Co., Ltd.
- 15.1.5. Eli Lilly and Company
- 15.1.6. F. Hoffmann La Roche Ltd.
- 15.1.7. GlaxoSmithKline PLC
- 15.1.8. Imugene Limited
- 15.1.9. Jiangsu Hengrui Medicine Co., Ltd.
- 15.1.10. Merck KGaA
- 15.1.11. Novartis AG
- 15.1.12. Otsuka Pharmaceutical Co., Ltd.
- 15.1.13. Pfizer, Inc.
- 15.1.14. Samsung Bioepis Co., Ltd.
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
- FIGURE 1. STOMACH CANCER TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. STOMACH CANCER TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. STOMACH CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. STOMACH CANCER TREATMENT MARKET DYNAMICS
- FIGURE 7. STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
- FIGURE 8. STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
- FIGURE 10. STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
- FIGURE 12. STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 14. STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 16. STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 20. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 25. STOMACH CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 26. STOMACH CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.